France - Potential Years of Life Lost from Prostate Malignant Neoplasms
Since 2014, France Potential Years of Life Lost from Prostate Malignant Neoplasms decreased by 2.7% year on year. In 2019, the country was number 32 among other countries in Potential Years of Life Lost from Prostate Malignant Neoplasms with 35.1 Years Per Hundred Thousand Men Aged 0-69. France is overtaken by Canada, which was number 31 at 38.3 Years Per Hundred Thousand Men Aged 0-69 and is followed by Spain at 33.8 Years Per Hundred Thousand Men Aged 0-69. Latvia topped the ranking with 119.4 Years Per Hundred Thousand Men Aged 0-69 in 2019, +0.2% versus 2018. South Africa, Estonia and Lithuania respectively ranked number 2, 3 and 4 in this ranking. Luxembourg witnessed the best average annual growth at +16.7% per year, while Iceland recorded the worst performance at -7.5% per year.
Loading...
Date | Years Per Hundred Thousand Men Aged 0-69 |
---|---|
2019 | 35.10 |
2018 | 36.30 |
2017 | 37.50 |
2016 | 38.60 |
2015 | 41.30 |
How does France rank in Potential Years of Life Lost from Prostate Malignant Neoplasms?
# | 39 Countries | Years Per Hundred Thousand Men Aged 0-69 | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Latvia
|
119.40 | 2019 | +0.2 % | -2.7 % | View data | |
2 |
#2
South Africa
|
108.20 | 2019 | +0.7 % | +1.4 % | View data | |
31 |
#31
Canada
|
38.30 | 2019 | -1.8 % | -0.9 % | View data | |
32 |
#32
France
|
35.10 | 2019 | -3.3 % | -2.7 % | View data | |
33 |
#33
Spain
|
33.80 | 2019 | -2.3 % | -1.9 % | View data |